A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Cao, Dongliang ^a   Kishida, Satoshi ^a   Huang, Peng ^a   Mu, Ping ^a   Tsubota, Shoma ^a   Mizuno, Masaaki ^b   Kadomatsu, Kenji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOETHANOL; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW METASTASIS; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CARCINOGENICITY; CELL RENEWAL; CULTURE MEDIUM; FETAL BOVINE SERUM; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NEUROBLASTOMA; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSGENIC MOUSE; TUMOR DIFFERENTIATION; TUMORSPHERE CULTURE;

ANIMALS; CATTLE; CELL CULTURE TECHNIQUES; CELLULAR MICROENVIRONMENT; MERCAPTOETHANOL; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS; SERUM; TUMOR CELLS, CULTURED;

EID: 84899561900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086813     Document Type: Article

References (23)

1. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, et al. (2010) A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17(4): 362-375.
2. Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, et al. (2007) Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 67(23): 11234-11243. (Pubitemid 350248549)
3. Nakagawara A, Ohira M. (2004) Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model. Cancer Letters 204(2): 213-224. (Pubitemid 38167724)
4. Brodeur GM. (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3(3): 203-216.
5. Huang P, Kishida S, Cao D, Murakami-Tonani Y, Mu P, et al. (2011) The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma. Cancer Res 71(8): 2938-2948.
6. Hanna JH, Saha K, Jaenisch R. (2010) Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143(4): 508-525.
7. Kamiya D, Banno S, Sasai N, Ohgushi M, Inomata H, et al. (2011) Intrinsic transition of embryonic stem-cell differentiation into neural progenitors. Nature 470(7335): 503-509.
8. Ang YS, Tsai SY, Lee DF, Monk J, Su J, et al. (2011) Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145(2): 183-197.
9. Hu Y, and Smyth GK (2009). ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. Journal of Immunological Methods 347: 70-78.
10. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5): 391-403. (Pubitemid 43668737)
11. Read TA, Wechsler-Reya RJ. (2012) Spheres without influence: dissociating in vitro self-renewal from tumorigenic potential in glioma. Cancer Cell 21(1): 1-3.
12. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66(19): 9339-9344.
13. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, et al. (2010) A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141(4): 583-594.
14. Kawauchi D, Robinson G, Uziel T, Gibson P, Rehg J, et al. (2012) A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 21(2): 168-180.
15. Barrett LE, Granot Z, Coker C, Iavarone A, Hambardzumyan D, et al. (2012) Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell 21(1): 11-24.
16. Tarek N, Le Luduec JB, Gallagher MM, Zheng J, Venstrom JM, et al. (2012) Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 122(9): 3260-3270.
17. Chen J, Li Y, Yu TS, Mckay RM, Burns DK, et al. (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 7412(488): 522-526.
18. Read TA, Fogarty MP, Markant SL, Mclendon RE, Wei Z, et al.(2009) Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell15(2): 135-147.
19. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, et al. (2000) Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28(1): 31-40.
20. Watanabe K, Kamiya D, Nishiyama A, Katayama T, Nozaki S, et al. (2005) Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci 8(3): 288-296. (Pubitemid 40300185)
21. Dong Fang, Thiennga K Nguyen, Kim Leishear, Rena Finko, Angela N Kulp, et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer research 65(20): 9328-9337.
22. Hsing-Chen Tsai, Huili Li, Leander Van Neste, Yi Cai, Carine Robert, et al. (2012) Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer cell 21(3): 430-446.
23. Chenfang Dong, Tingting Yuan, Yadi Wu, Yifan Wang, Teresa W.M Fan, et al. (2013) Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer cell 23(3): 316-331. Technology Technology Technology